|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:TNIP1-VIM (FusionGDB2 ID:92072) |
Fusion Gene Summary for TNIP1-VIM |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: TNIP1-VIM | Fusion gene ID: 92072 | Hgene | Tgene | Gene symbol | TNIP1 | VIM | Gene ID | 10318 | 7431 |
| Gene name | TNFAIP3 interacting protein 1 | vimentin | |
| Synonyms | ABIN-1|NAF1|VAN|nip40-1 | - | |
| Cytomap | 5q33.1 | 10p13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | TNFAIP3-interacting protein 1A20-binding inhibitor of NF-kappa-B activation 1HIV-1 Nef-interacting proteinNef-associated factor 1 SNPvirion-associated nuclear shuttling protein | vimentinepididymis secretory sperm binding protein | |
| Modification date | 20200327 | 20200327 | |
| UniProtAcc | Q15025 | VMAC | |
| Ensembl transtripts involved in fusion gene | ENST00000520931, ENST00000389378, ENST00000523338, ENST00000315050, ENST00000522226, ENST00000518977, ENST00000521591, ENST00000524280, ENST00000523200, ENST00000521423, | ENST00000544301, ENST00000224237, ENST00000485947, | |
| Fusion gene scores | * DoF score | 11 X 10 X 7=770 | 42 X 25 X 11=11550 |
| # samples | 11 | 41 | |
| ** MAII score | log2(11/770*10)=-2.8073549220576 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(41/11550*10)=-4.81612513168534 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: TNIP1 [Title/Abstract] AND VIM [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | TNIP1(150409573)-VIM(17271771), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | TNIP1 | GO:0009101 | glycoprotein biosynthetic process | 9923610 |
| Hgene | TNIP1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 16684768 |
| Hgene | TNIP1 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 12220502 |
| Hgene | TNIP1 | GO:0085032 | modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade | 20010814 |
| Hgene | TNIP1 | GO:1903003 | positive regulation of protein deubiquitination | 16684768 |
| Fusion gene breakpoints across TNIP1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene breakpoints across VIM (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS5.0 | N/A | AA368174 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
Top |
Fusion Gene ORF analysis for TNIP1-VIM |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000520931 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000520931 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000520931 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000389378 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000389378 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000389378 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000523338 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000523338 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000523338 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000315050 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000315050 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000315050 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000522226 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000522226 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000522226 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000518977 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000518977 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000518977 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000521591 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000521591 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000521591 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000524280 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000524280 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000524280 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000523200 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000523200 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000523200 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000521423 | ENST00000544301 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3CDS | ENST00000521423 | ENST00000224237 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| intron-3UTR | ENST00000521423 | ENST00000485947 | TNIP1 | chr5 | 150409573 | + | VIM | chr10 | 17271771 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for TNIP1-VIM |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TNIP1-VIM |
| Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| TNIP1 | VIM |
| FUNCTION: Inhibits NF-kappa-B activation and TNF-induced NF-kappa-B-dependent gene expression by regulating A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG. Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti-inflammatory response of macrophages and positively regulates TLR-induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection. {ECO:0000269|PubMed:12220502, ECO:0000269|PubMed:16684768, ECO:0000269|PubMed:17016622, ECO:0000269|PubMed:17632516, ECO:0000269|PubMed:20010814}. | 169 |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for TNIP1-VIM |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for TNIP1-VIM |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TNIP1-VIM |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TNIP1-VIM |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | TNIP1 | C0024141 | Lupus Erythematosus, Systemic | 7 | CTD_human;ORPHANET |
| Hgene | TNIP1 | C0030246 | Pustulosis of Palms and Soles | 2 | CTD_human |
| Hgene | TNIP1 | C0033860 | Psoriasis | 2 | CTD_human |
| Hgene | TNIP1 | C0242380 | Libman-Sacks Disease | 2 | CTD_human |
| Hgene | TNIP1 | C0004096 | Asthma | 1 | CTD_human |
| Hgene | TNIP1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| Hgene | TNIP1 | C0036421 | Systemic Scleroderma | 1 | CTD_human |
| Hgene | TNIP1 | C0086981 | Sicca Syndrome | 1 | CTD_human |
| Hgene | TNIP1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Hgene | TNIP1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Hgene | TNIP1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | TNIP1 | C1527336 | Sjogren's Syndrome | 1 | CTD_human |
| Hgene | TNIP1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
| Tgene | VIM | C0006142 | Malignant neoplasm of breast | 4 | CTD_human |
| Tgene | VIM | C0678222 | Breast Carcinoma | 4 | CTD_human |
| Tgene | VIM | C1257931 | Mammary Neoplasms, Human | 4 | CTD_human |
| Tgene | VIM | C1458155 | Mammary Neoplasms | 4 | CTD_human |
| Tgene | VIM | C3805411 | CATARACT 30 | 4 | GENOMICS_ENGLAND;UNIPROT |
| Tgene | VIM | C4704874 | Mammary Carcinoma, Human | 4 | CTD_human |
| Tgene | VIM | C0023890 | Liver Cirrhosis | 2 | CTD_human |
| Tgene | VIM | C0029408 | Degenerative polyarthritis | 2 | CTD_human |
| Tgene | VIM | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
| Tgene | VIM | C0086743 | Osteoarthrosis Deformans | 2 | CTD_human |
| Tgene | VIM | C0239946 | Fibrosis, Liver | 2 | CTD_human |
| Tgene | VIM | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human |
| Tgene | VIM | C0007140 | Carcinosarcoma | 1 | CTD_human |
| Tgene | VIM | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
| Tgene | VIM | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
| Tgene | VIM | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
| Tgene | VIM | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| Tgene | VIM | C0027627 | Neoplasm Metastasis | 1 | CTD_human |
| Tgene | VIM | C0027720 | Nephrosis | 1 | CTD_human |
| Tgene | VIM | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
| Tgene | VIM | C0035126 | Reperfusion Injury | 1 | CTD_human |
| Tgene | VIM | C0035309 | Retinal Diseases | 1 | CTD_human |
| Tgene | VIM | C0039101 | synovial sarcoma | 1 | CTD_human |
| Tgene | VIM | C0043094 | Weight Gain | 1 | CTD_human |
| Tgene | VIM | C0085084 | Motor Neuron Disease | 1 | CTD_human |
| Tgene | VIM | C0086543 | Cataract | 1 | CTD_human |
| Tgene | VIM | C0154681 | Anterior Horn Cell Disease | 1 | CTD_human |
| Tgene | VIM | C0154682 | Lateral Sclerosis | 1 | CTD_human |
| Tgene | VIM | C0270715 | Degenerative Diseases, Central Nervous System | 1 | CTD_human |
| Tgene | VIM | C0270763 | Familial Motor Neuron Disease | 1 | CTD_human |
| Tgene | VIM | C0270764 | Motor Neuron Disease, Lower | 1 | CTD_human |
| Tgene | VIM | C0345967 | Malignant mesothelioma | 1 | CTD_human |
| Tgene | VIM | C0346990 | Carcinomatosis of peritoneal cavity | 1 | CTD_human |
| Tgene | VIM | C0521659 | Motor Neuron Disease, Upper | 1 | CTD_human |
| Tgene | VIM | C0524524 | Pseudoaphakia | 1 | CTD_human |
| Tgene | VIM | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
| Tgene | VIM | C0543858 | Motor Neuron Disease, Secondary | 1 | CTD_human |
| Tgene | VIM | C0751733 | Degenerative Diseases, Spinal Cord | 1 | CTD_human |
| Tgene | VIM | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
| Tgene | VIM | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
| Tgene | VIM | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
| Tgene | VIM | C1510497 | Lens Opacities | 1 | CTD_human |
| Tgene | VIM | C1833118 | Cataract, Pulverulent | 1 | ORPHANET |
| Tgene | VIM | C1852438 | CATARACT, COPPOCK-LIKE | 1 | ORPHANET |
| Tgene | VIM | C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | CTD_human |
| Tgene | VIM | C1862941 | Amyotrophic Lateral Sclerosis, Sporadic | 1 | CTD_human |
| Tgene | VIM | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
| Tgene | VIM | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| Tgene | VIM | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
| Tgene | VIM | C4551993 | Amyotrophic Lateral Sclerosis, Familial | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies